U.S. flag

An official website of the United States government

Talk to the Veterans Crisis Line now
Skip to main content
A veteran in front of a computer holding a pen device, discussing the medication with a healthcare provider via video call. A tagline at the top reading, "Centralized Specialty Medication Management. Helping Veterans with medication since 2020."

Last updated

Centralized Specialty Medication Management

Share Print

Specialty medications taken at home are expensive, complex to administer, and have unique side effect profiles. Centralized Specialty Medication Management (CSMM) connects specialty pharmacists with Veterans initiating select specialty medications for detailed education and close monitoring. This innovation contains costs (with a positive ROI) and improves medication safety while achieving high satisfaction from both Veterans and providers.

This innovation is emerging and worth watching as it is being assessed in early implementations. See more emerging innovations.

Adoptions:

2 successful, 1 in-progress

Awards and Recognition:

Clinical Pharmacy Practice Office Best Practice

Partners:

Academic Affiliations, Clinical Pharmacy Practice Office, Dermatology, Gastroenterology and Hepatology, Neurology, Rheumatology

Contact Team

Overview

Problem

Specialty medication can drastically improve patient health and quality of life but are very expensive. Prior to the approval of currently available specialty medications, work disability impacted 22-44% of patients with rheumatoid arthritis. Biologic agents, a subset of specialty medications, can allow Veterans to return to normalcy and improve the associat ... See more

Images

Figure 1 showing 3 main problems associated with specialty medications: cost, complex side effects, and difficult to use

Problems associated with specialty medications include cost, complex side effects, and are difficult to use

Solution

The Centralized Specialty Medication Management (CSMM) clinic presents an opportunity for VHA to embed ambulatory care specialty pharmacists to closely monitor Veterans on specialty medications and coordinate care with specialty providers. CSMM improves quality of care and adherence while containing costs. To support Veterans initiating specialty medications ... See more

Images

A poster containing information about the general overview of CSMM including background, service description, results, conclusions and future directions

Poster presentation by PharmD Albright, White, Simonet and Margolis given at ASHP Midyear

Two people reviewing a biologic specialty medication

Pharmacist completing education for a biologic specialty medication

Links

Results

The CSMM clinic has established feasibility at two VA systems (Madison, WI and Milwaukee, WI). During the first year of the Madison VA CSMM clinic, pharmacists conducted 28 new medication educations, 133 follow-ups, made 11 medication changes, and 5 medication storage corrections. Today, the Madison VA CSMM clinic manages about 175 patients annually, totalin ... See more

Images

A Veteran on a call with providers sharing her thoughts about the CSMM clinic

Veteran testimonial about CSMM clinic

Metrics

  • Veterans were 25% less likely to discontinue their new biologic at one year due to adverse effects. This was attributed to management of injection site reactions (60% CSMM, 13% control; p=0.009). Figure 1
  • CSMM pharmacists make or recommended medication changes for 1 in 5 Veterans and corrected storage requirements in 1 in 10 Veterans. Table 1
  • CSMM clinic conservatively save $787 per patient seen. The cost avoidance related to CPP interventions was 149% compared to the cost of the pharmacist to run the clinic. Cost savings was primarily due to medication adjustments and replacement of defective devices.
  • CSMM service has high Veteran satisfaction with a mean overall satisfaction of 4.92 out of 5 (excellent). All patients said they would choose to use CSMM again if prescribed a new specialty medication.
  • In January 2024, the Milwaukee VA implemented CSMM and corrected injection technique in 40.5% of patients. Figure 2

Diffusion tracker

Does not include Clinical Resource Hubs (CRH)

Statuses

WI: Tomah VA Medical Center (Tomah)
  • Started adoption on 05/2024.

There are no unsuccessful adoptions for this innovation.

Multimedia

Images

A table showing outcomes from the Madison and Milwaukee VA with multiple interventions including injection technique intervention and care coordination among others.

Table 1: CSMM outcomes following Biologic Medication initiation.

Kaplan Meier survival plots showing the overall time on agents prior to discontinuation, comparing CSMM to regular care

Figure 1. Kaplan Meier survival plots agents comparing CSMM and usual care for medication discontinuation due to safefy.

A poster presenting information and results about the CSMM expansion to the Milwaukee VA including, background, objectives, service description, results, discussion, limitations, and future directions.

Figure 2. Poster presentation by PharmD Furley, Margolis, Uildriks, Jablonski, McGill and Koch given at Pharmacy Society of Wisconsin 2024 Educational Conference

Implementation

Timeline

  • Month 0
    - Review the Clinical Pharmacy Practice Office CSMM toolkit
    - Identify medications for CSMM and subsequent patient volume of new medication starts (Suggested initial medications: adalimumab, etanercept, ixekizumab, risankizumab, secukinumab, ustekinumab)
    - Identify current process for new biologic medication education and ongoing monitoring/maintenance
    -Meet with pharmacy leadership
  • Month 1
    - Establish workgroup of CSMM pharmacists, pharmacy leadership, and key specialty providers for service development and collaboration
    - Ensure all CSMM pharmacists have allocated time for program development and management
  • Month 2-3
    - Dedicate necessary time and staff to CSMM clinic (for initial clinic implementation, recommend ratio of 0.1 pharmacist FTE per 50 annual new formulary approvals)
    - Develop necessary clinic materials, including templates, disease state questionnaires, patient education materials, and scope of practice
    - Submit new clinic grid request through local process
  • Month 4-5
    - Marketing of service in collaboration with specialty clinics and specialty providers
    - Self-education of the Clinical Pharmacy Practitioner (CPP) if needed
    - Consider new CSMM pharmacists shadowing established CSMM pharmacists at other VAs (can be virtual)
  • Month 5-6
    - Patient identification and scheduling
    - Begin seeing patients
    - Take note of inefficiencies or pressure points during initial implementation
    - Reach out to other VAs with established CSMM clinics for collaboration and suggestions
  • Ongoing
    - Track clinic utilization and productivity
    - Consider expanding list of biologic medication, disease states and specialty clinics
    - Consider conducting patient satisfaction interviews and/or tracking CPP interventions

Departments

  • Dermatology
  • Gastroenterology
  • Pharmacy
  • Allergy, asthma and immunology
  • Rheumatology
  • Neurology

Core Resources

Resource type Resource description
PEOPLE
  • Pharmacist FTE: 0.1-0.2 FTE to manage 600,000$-1,200,000$ of medication use for improved Veteran care and budget stewardship. May consider re-allocation of pharmacist FTE from ambulatory care or formulary.
  • Scheduling assistance, generally MSA or pharmacy technician (about 1 hour per 0.1 pharmacist FTE per week)
  • Informatics assistance for specialty medication approval reports
PROCESSES
  • Ensure team members have ongoing allocated time for program development and management (0.5-1 hour per pharmacist FTE per week)
TOOLS
  • CPRS panel creation (Phone, VVC, potentially face-to-face)
  • Secure Messaging access
  • Phone
  • Camera for VVC capability

Links

Support Resources

Resource type Resource description
PROCESSES
  • Quarterly conference calls with other CSMM VA facilities
TOOLS
  • Demonstration Devices for high cost/high risk medications (i.e. Hadlima, Stelara and Skyrizi)
  • Phone line (Jabber) with voicemail capabilities
  • Consider remote work capabilities

Risks and mitigations

Risk Mitigation
Pharmacist FTE CSMM supports pharmacy budget stewardship and saves more money than it costs to run the clinic.

VAs interested in implementing a CSMM clinic can consider re-allocation from among ambulatory care and/or formulary pharmacists.

Contact

Comment

Comments and replies are disabled for retired innovations and non-VA users.

Email

Email with questions about this innovation.

About

Origin story

The Madison VA has a progressive pharmacy practice with a strong history of innovation. In recent years, there was an increase in specialty medication use and associated cost. Many specialty clinics had an increase in specialty medication prescribing specialty medications without an embedded pharmacist. In 2019 discussions began to pilot a pharmacist-managed ... The Madison VA has a progressive pharmacy practice with a strong history of innovation. In recent years, there was an increase in specialty medication use and associated cost. Many specialty clinics had an increase in specialty medication prescribing specialty medications without an embedded pharmacist. In 2019 discussions began to pilot a pharmacist-managed centralized specialty medication management program to improve Veteran education on specialty medications with close monitoring. This allowed for improved Veteran care and pharmacy budget stewardship.

Original team

Tyler Albright

Clinical Pharmacy Practitioner

Amanda Margolis

Clinical Pharmacy Practitioner; Associate Professor

Anna White

Clinical Pharmacy Practitioner

Ryan Simonet

Clinical Pharmacy Practitioner

Ellina Seckel

Associate Chief of Pharmacy

Andrew Wilcox

Chief of Pharmacy